Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of AJU-S56 in Dry Eye Disease
NCT06337981Phase 2Completed
- Sponsor
- AJU PHARM Co., Ltd.
- Start
- Nov 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye disease (DED) (3 arms), sponsored by AJU PHARM Co., Ltd. Primary endpoint: Total Corneal Staining Score at 4 weeks. Started Nov 2021; status: completed.
02
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT06337981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06337981.